151 related articles for article (PubMed ID: 8879435)
1. Inhibition of LDL oxidation and myeloperoxidase dependent tyrosyl radical formation by the selective estrogen receptor modulator raloxifene (LY139481 HCL).
Zuckerman SH; Bryan N
Atherosclerosis; 1996 Sep; 126(1):65-75. PubMed ID: 8879435
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of LDL oxidation by a new estradiol receptor modulator compound LY-139478, comparative effect with other steroids.
Rattan AK; Arad Y
Atherosclerosis; 1998 Feb; 136(2):305-14. PubMed ID: 9543102
[TBL] [Abstract][Full Text] [Related]
3. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein.
Savenkova ML; Mueller DM; Heinecke JW
J Biol Chem; 1994 Aug; 269(32):20394-400. PubMed ID: 8051134
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the oxidative modification of LDL by nitecapone.
Pentikäinen MO; Lindstedt KA; Kovanen PT
Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):740-7. PubMed ID: 7773727
[TBL] [Abstract][Full Text] [Related]
5. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
Hazen SL; Heinecke JW
J Clin Invest; 1997 May; 99(9):2075-81. PubMed ID: 9151778
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of heparin-treated low density lipoprotein by peroxidases.
Upritchard JE; Sutherland WH
Atherosclerosis; 1999 Oct; 146(2):211-9. PubMed ID: 10532677
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the macrophage-induced oxidation of low density lipoprotein by interferon-gamma.
Fong LG; Albert TS; Hom SE
J Lipid Res; 1994 May; 35(5):893-904. PubMed ID: 8071611
[TBL] [Abstract][Full Text] [Related]
8. Effects of resveratrol on oxidative modification of human low density lipoprotein.
Zou J; Huang Y; Chen Q; Wei E; Cao K; Wu JM
Chin Med J (Engl); 2000 Feb; 113(2):99-102. PubMed ID: 11775553
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques.
Leeuwenburgh C; Rasmussen JE; Hsu FF; Mueller DM; Pennathur S; Heinecke JW
J Biol Chem; 1997 Feb; 272(6):3520-6. PubMed ID: 9013599
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of low density lipoprotein oxidation by thyronines and probucol.
Hanna AN; Feller DR; Witiak DT; Newman HA
Biochem Pharmacol; 1993 Feb; 45(3):753-62. PubMed ID: 8442772
[TBL] [Abstract][Full Text] [Related]
11. The effect of inhibitors of free radical generating-enzymes on low-density lipoprotein oxidation by macrophages.
Wilkins GM; Leake DS
Biochim Biophys Acta; 1994 Feb; 1211(1):69-78. PubMed ID: 7510129
[TBL] [Abstract][Full Text] [Related]
12. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
[TBL] [Abstract][Full Text] [Related]
13. Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals.
Noguchi N; Gotoh N; Niki E
Biochim Biophys Acta; 1994 Jul; 1213(2):176-82. PubMed ID: 8025128
[TBL] [Abstract][Full Text] [Related]
14. Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine.
Heinecke JW
Biofactors; 1997; 6(2):145-55. PubMed ID: 9259996
[TBL] [Abstract][Full Text] [Related]
15. Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies.
Rosenblat M; Aviram M
Free Radic Biol Med; 1998 Jan; 24(2):305-17. PubMed ID: 9433906
[TBL] [Abstract][Full Text] [Related]
16. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation.
Hanna AN; Titterington LC; Lantry LE; Stephens RE; Newman HA
Biochem Pharmacol; 1995 Nov; 50(10):1627-33. PubMed ID: 7503765
[TBL] [Abstract][Full Text] [Related]
17. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.
Bagnati M; Perugini C; Cau C; Bordone R; Albano E; Bellomo G
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):143-52. PubMed ID: 10229669
[TBL] [Abstract][Full Text] [Related]
18. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells.
Francis GA; Mendez AJ; Bierman EL; Heinecke JW
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6631-5. PubMed ID: 8341680
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of low density lipoprotein oxidation by 17-alpha estradiol.
Dittrich R; Müller A; Hensen J; Wildt L
Exp Clin Endocrinol Diabetes; 1999; 107(1):53-7. PubMed ID: 10077356
[TBL] [Abstract][Full Text] [Related]
20. Salicylate promotes myeloperoxidase-initiated LDL oxidation: antagonization by its metabolite gentisic acid.
Hermann M; Kapiotis S; Hofbauer R; Seelos C; Held I; Gmeiner B
Free Radic Biol Med; 1999 May; 26(9-10):1253-60. PubMed ID: 10381197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
